مراجع و رفرنس های دوره کنترل عفونت

در اینجا مراجع و رفرنس هایی که در دوره کنترل عفونت به آنها ارجاع داده شده است را ملاحظه می کنید

References

1. CDC. Recommended infection-control practices for dentistry. MMWR
   1986;35:237–42.
2. CDC. Recommended infection-control practices for dentistry, 1993.
   MMWR 1993;42(No. RR-8).
3. US Census Bureau. Statistical Abstract of the United States: 2001.
   Washington, DC: US Census Bureau, 2001. Available at http://www.
   census.gov/prod/www/statistical-abstract-02.html.
4. Health Resources and Services Administration, Bureau of Health Professions. United States health workforce personnel factbook. Rockville,
   MD: US Department of Health and Human Services, Health Resources
   and Services Administration, 2000.
5. Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN,
   Deitchman SD, Hospital Infection Control Practices Advisory Committee. Guideline for infection control in health care personnel, 1998.
   Am J Infect Control 1998;26:289–354.
6. Greene VW. Microbiological contamination control in hospitals.
7. Perspectives. Hospitals 1969;43:78–88.
8. CDC. Perspectives in disease prevention and health promotion
   update: universal precautions for prevention of transmission of
   human immunodeficiency virus, hepatitis B virus, and other bloodborne
   pathogens in health-care settings. MMWR 1988;38:377–382, 387–8.
   Vol. 52 / RR-17 Recommendations and Reports 49
9. CDC. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety
   workers: a response to P.L. 100-607 The Health Omnibus Programs
   Extension Act of 1988. MMWR 1989;38(suppl No. 6S).
10. Garner JS, Favero MS. CDC guideline for handwashing and hospital
    environmental control, 1985. Infect Control 1986;7:231–43.
11. CDC. Recommendations for prevention of HIV transmission in healthcare settings. MMWR 1987;36(suppl No. 2S).
12. Garner JS, Hospital Infection Control Practices Advisory Committee.
    Guideline for isolation precautions in hospitals. Infect Control Hosp
    Epidemiol 1996;17:53–80.
13. Chiarello LA, Bartley J. Prevention of blood exposure in healthcare
    personnel. Seminars in Infection Control 2001;1:30–43.
14. US Department of Labor, Occupational Safety and Health Administration. 29 CFR Part 1910.1030. Occupational exposure to bloodborne
    pathogens; needlesticks and other sharps injuries; final rule. Federal
    Register 2001;66:5317–25. As amended from and includes 29 CFR
    Part 1910.1030. Occupational exposure to bloodborne pathogens;
    final rule. Federal Register 1991;56:64174–82. Available at http://www.
    osha.gov/SLTC/dentistry/index.html.
15. US Department of Labor, Occupational Safety and Health Administration. OSHA instruction: enforcement procedures for the occupational exposure to bloodborne pathogens. Washington, DC: US
    Department of Labor, Occupational Safety and Health Administration, 2001; directive no. CPL 2-2.69.
16. US Department of Labor, Occupational Safety and Health Administration. 29 CFR 1910.1200. Hazard communication. Federal Register 1994;59:17479.
17. Gershon RR, Karkashian CD, Grosch JW, et al. Hospital safety climate and its relationship with safe work practices and workplace exposure incidents. Am J Infect Control 2000;28:211–21.
18. CDC. Immunization of health-care workers: recommendations of the
    Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC).
    MMWR 1997;46(No. RR-18).
19. Association for Professionals in Infection Control and Epidemiology. APIC
    position paper: immunization. Am J Infect Control 1999;27:52–3.
20. CDC. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 2001;50(No. RR-11).
21. CDC. Guidelines for preventing the transmission of Mycobacterium
    tuberculosis in health-care facilities, 1994. MMWR 1994;43(No. RR-13).
22. Cleveland JL, Gooch BF, Bolyard EA, Simone PM, Mullan RJ,
    Marianos DW. TB infection control recommendations from the CDC,
    1994: considerations for dentistry. J Am Dent Assoc 1995;126:593–9.
23. Herwaldt LA, Pottinger JM, Carter CD, Barr BA, Miller ED. Exposure workups. Infect Control Hosp Epidemiol 1997;18:850–71.
24. Nash KD. How infection control procedures are affecting dental practice today. J Am Dent Assoc 1992;123:67–73.
25. Berky ZT, Luciano WJ, James WD. Latex glove allergy: a survey of the
    US Army Dental Corps. JAMA 1992;268:2695–7.
26. Bubak ME, Reed CE, Fransway AF, et al. Allergic reactions to latex
    among health-care workers. Mayo Clin Proc 1992;67:1075–9.
27. Fisher AA. Allergic contact reactions in health personnel. J Allergy Clin
    Immunol 1992;90:729–38.
28. Smart ER, Macleod RI, Lawrence CM. Allergic reactions to rubber gloves
    in dental patients: report of three cases. Br Dent J 1992;172:445–7.
29. Yassin MS, Lierl MB, Fischer TJ, O’Brien K, Cross J, Steinmetz C.
    Latex allergy in hospital employees. Ann Allergy 1994;72:245–9.
30. Zaza S, Reeder JM, Charles LE, Jarvis WR. Latex sensitivity among
    perioperative nurses. AORN J 1994;60:806–12.
31. Hunt LW, Fransway AF, Reed CE, et al. An epidemic of occupational
    allergy to latex involving health care workers. J Occup Environ Med
    1995;37:1204–9.
32. American Dental Association Council on Scientific Affairs. The dental
    team and latex hypersensitivity. J Am Dent Assoc 1999;130:257–64.
33. CDC. National Institute for Occupational Safety and Health. NIOSH
    Alert: preventing allergic reactions to natural rubber latex in the workplace. Cincinnati, OH: US Department of Health and Human Services, Public Health Service, CDC, National Institute for Occupational
    Safety and Health, 1997.
34. Terezhalmy GT, Molinari JA. Personal protective equipment and barrier techniques. In: Cottone JA, Terezhalmy GT, Molinari JA, eds. Practical infection control in dentisty. 2nd ed. Baltimore, MD: Williams &
    Wilkins, 1996:136–145.
35. US Department of Health and Human Services, Office of the Secretary, Office for Civil Rights. 45 CFR Parts 160 and 164. Standards for
    privacy of individually identifiable health information; final rule. Federal Register 2000;65:82462–829.
36. Occupational Safety and Health Administration. Access to medical
    and exposure records. Washington, DC: US Department of Labor,
    Occupational Safety and Health Administration, 2001. OSHA publication no. 3110.
37. Mast EE, Alter MJ. Prevention of hepatitis B virus infection among
    health-care workers. In: Ellis RW, ed. Hepatitis B vaccines in clinical
    practice. New York, NY: Marcel Dekker, 1993:295–307.
38. Beltrami EM, Williams IT, Shapiro CN, Chamberland ME. Risk and
    management of blood-borne infections in health care workers. Clin
    Microbiol Rev 2000;13:385–407.
39. Werner BG, Grady GF. Accidental hepatitis-B-surface-antigenpositive inoculations: use of e antigen to estimate infectivity. Ann
    Intern Med 1982;97:367–9.
40. Bond WW, Petersen NJ, Favero MS. Viral hepatitis B: aspects of environmental control. Health Lab Sci 1977;14:235–52.
41. Garibaldi RA, Hatch FE, Bisno AL, Hatch MH, Gregg MB.
    Nonparenteral serum hepatitis: report of an outbreak. JAMA 1972;
    220:963–6.
42. Rosenberg JL, Jones DP, Lipitz LR, Kirsner JB. Viral hepatitis: an
    occupational hazard to surgeons. JAMA 1973;223:395–400.
43. Callender ME, White YS, Williams R. Hepatitis B virus infection in
    medical and health care personnel. Br Med J 1982;284:324–6.
44. Chaudhuri AK, Follett EA. Hepatitis B virus infection in medical and
    health care personnel [Letter]. Br Med J 1982;284:1408.
45. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard
    JE. Survival of hepatitis B virus after drying and storage for one week
    [Letter]. Lancet 1981;1:550–1.
46. Francis DP, Favero MS, Maynard JE. Transmission of hepatitis B virus
    [Review]. Semin Liver Dis 1981;1:27–32.
47. Favero MS, Maynard JE, Petersen NJ, et al. Hepatitis-B antigen on
    environmental surfaces [Letter]. Lancet 1973;2:1455.
48. Lauer JL, VanDrunen NA, Washburn JW, Balfour HH Jr. Transmission of hepatitis B virus in clinical laboratory areas. J Infect Dis
    1979;140:513–6.
49. Hennekens CH. Hemodialysis-associated hepatitis: an outbreak among
    hospital personnel. JAMA 1973;225:407–8.
50. Garibaldi RA, Forrest JN, Bryan JA, Hanson BF, Dismukes WE.
    Hemodialysis-associated hepatitis. JAMA 1973;225:384–9.
    50 MMWR December 19, 2003
51. Snydman DR, Bryan JA, Macon EJ, Gregg MB. Hemodialysis-associated
    hepatitis: a report of an epidemic with further evidence on mechanisms of transmission. Am J Epidemiol 1976;104:563–70.
52. Shapiro CN. Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am 1995;75:1047–56.
53. Cleveland JL, Siew C, Lockwood SA, Gruninger SE, Gooch BF, Shapiro
    CN. Hepatitis B vaccination and infection among U.S. dentists, 1983–
54. J Am Dent Assoc 1996;127:1385–90.
55. CDC. Recommendations for preventing transmission of human
    immunodeficiency virus and hepatitis B virus to patients during
    exposure-prone invasive procedures. MMWR 1991;40(No. RR-8).
56. Chamberland ME. HIV transmission from health care worker to
    patient: what is the risk [Letter]? Ann Intern Med 1992;116:871–3.
57. Robert LM, Chamberland ME, Cleveland JL, et al. Investigation of
    patients of health care workers infected with HIV: the Centers for Disease
    Control and Prevention database. Ann Intern Med 1995;122:653–7.
58. CDC. Investigations of persons treated by HIV-infected health-care
    workers—United States. MMWR 1993;42:329–331, 337.
59. Siew C, Chang SB, Gruninger SE, Verrusio AC, Neidle EA. Selfreported percutaneous injuries in dentists: implications for HBV, HIV,
    transmission risk. J Am Dent Assoc 1992;123:36–44.
60. Ahtone J, Goodman RA. Hepatitis B and dental personnel: transmission
    to patients and prevention issues. J Am Dent Assoc 1983;106:219–22.
61. Hadler SC, Sorley DL, Acree KH, et al. An outbreak of hepatitis B in
    a dental practice. Ann Intern Med 1981;95:133–8.
62. CDC. Epidemiologic notes and reports: hepatitis B among dental
    patients—Indiana. MMWR 1985;34:73–5.
63. Levin ML, Maddrey WC, Wands JR, Mendeloff AL. Hepatitis B transmission by dentists. JAMA 1974;228:1139–40.
64. Rimland D, Parkin WE, Miller GB Jr, Schrack WD. Hepatitis B outbreak traced to an oral surgeon. N Engl J Med 1977;296:953–8.
65. Goodwin D, Fannin SL, McCracken BB. An oral surgeon-related
    hepatitis-B outbreak. California Morbidity 1976;14:1.
66. Reingold AL, Kane MA, Murphy BL, Checko P, Francis DP, Maynard
    JE. Transmission of hepatitis B by an oral surgeon. J Infect Dis 1982;
    145:262–8.
67. Goodman RA, Ahtone JL, Finton RJ. Hepatitis B transmission from
    dental personnel to patients: unfinished business. Ann Intern Med
    1982;96:119.
68. Shaw FE Jr, Barrett CL, Hamm R, et al. Lethal outbreak of hepatitis B
    in a dental practice. JAMA 1986;255:3260–4.
69. CDC. Epidemiologic notes and reports: outbreak of hepatitis B associated with an oral surgeon—New Hampshire. MMWR 1987;36:132–3.
70. US Department of Labor, Occupational Safety and Health Administration. 29 CFR Part 1910.1030. Occupational exposure to bloodborne
    pathogens; final rule. Federal Register 1991;56:64004–182.
71. CDC. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination:
    recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(No. RR-13).
72. Polish LB, Gallagher M, Fields HA, Hadler SC. Delta hepatitis:
    molecular biology and clinical and epidemiological features. Clin
    Microbiol Rev 1993;6:211–29.
73. Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin
    Liver Dis 1997;1:559–68.
74. Puro V, Petrosillo N, Ippolito G. Risk of hepatitis C seroconversion
    after occupational exposures in health care workers: Italian Study Group
    on Occupational Risk of HIV and Other Bloodborne Infections. Am J
    Infect Control 1995;23:273–7.
75. Lanphear BP, Linnemann CC Jr, Cannon CG, DeRonde MM, Pendy
    L, Kerley LM. Hepatitis C virus infection in healthcare workers: risk
    of exposure and infection. Infect Control Hosp Epidemiol 1994;
    15:745–50.
76. Mitsui T, Iwano K, Masuko K, et al. Hepatitis C virus infection in
    medical personnel after needlestick accident. Hepatology 1992;16:
    1109–14.
77. Sartori M, La Terra G, Aglietta M, Manzin A, Navino C, Verzetti G.
    Transmission of hepatitis C via blood splash into conjunctiva. Scand
    J Infect Dis 1993;25:270–1.
78. Ippolito G, Puro V, De Carli G. The risk of occupational human
    immunodeficiency virus in health care workers: Italian Multicenter
    Study, The Italian Study Group on Occupational Risk of HIV Infection. Arch Intern Med 1993;153:1451–8.
79. Beltrami EM, Kozak A, Williams IT, et al. Transmission of HIV and
    hepatitis C virus from a nursing home patient to a health care worker.
    Am J Infec Control. 2003; 31:168–75.
80. Cooper BW, Krusell A, Tilton RC, Goodwin R, Levitz RE.
    Seroprevalence of antibodies to hepatitis C virus in high-risk hospital
    personnel. Infect Control Hosp Epidemiol 1992;13:82–5.
81. Panlilio AL, Shapiro CN, Schable CA, et al. Serosurvey of human
    immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group. J Am
    Coll Surg 1995;180:16–24.
82. Polish LB, Tong MJ, Co RL, Coleman PJ, Alter MJ. Risk factors for
    hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993;21:196–200.
83. Shapiro CN, Tokars JI, Chamberland ME, American Academy of
    Orthopaedic Surgeons Serosurvey Study Committee. Use of the
    hepatitis-B vaccine and infection with hepatitis B and C among
    orthopaedic surgeons. J Bone Joint Surg Am 1996;78:1791–800.
84. Gerberding JL. Incidence and prevalence of human immunodeficiency
    virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among
    health care personnel at risk for blood exposure: final report from a
    longitudinal study. J Infect Dis 1994;170:1410–7.
85. Klein RS, Freeman K, Taylor PE, Stevens CE. Occupational risk for
    hepatitis C virus infection among New York City dentists. Lancet
    1991;338:1539–42.
86. Thomas DL, Gruninger SE, Siew C, Joy ED, Quinn TC. Occupational risk of hepatitis C infections among general dentists and oral
    surgeons in North America. Am J Med 1996;100:41–5.
87. Cleveland JL, Gooch BF, Shearer BG, Lyerla RL. Risk and prevention
    of hepatitis C virus infection: implications for dentistry. J Am Dent
    Assoc 1999;130:641–7.
88. Gruninger SE, Siew C, Azzolin KL, Meyer DM. Update of hepatitis C
    infection among dental professionals [Abstract 1825]. J Dent Res
    2001;80:264.
89. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C
    virus by a cardiac surgeon. N Engl J Med 1996;334:555–60.
90. Duckworth GJ, Heptonstall J, Aitken C. Transmission of hepatitis C
    virus from a surgeon to a patient: the Incident Control Team. Commun
    Dis Public Health 1999;2:188–92.
91. Ross RS, Viazov S, Gross T, Hofmann F, Seipp HM, Roggendorf M.
    Brief report: transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients. N Engl J Med 2000;343:1851–4.
92. Cody SH, Nainan OV, Garfein RS, et al. Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med 2002;
    162:345–50.
    Vol. 52 / RR-17 Recommendations and Reports 51
93. Do AN, Ciesielski CA, Metler RP, Hammett TA, Li J, Fleming PL.
    Occupationally acquired human immunodeficiency virus (HIV)
    infection: national case surveillance data during 20 years of the HIV
    epidemic in the United States. Infect Control Hosp Epidemiol
    2003;24:86–96.
94. Ciesielski C, Marianos D, Ou CY, et al. Transmission of human
    immunodeficiency virus in a dental practice. Ann Intern Med 1992;
    116:798–805.
95. CDC. Investigations of patients who have been treated by HIVinfected health-care workers—United States. MMWR 1993;42:
    329–31, 337.
96. Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997;102(5B):9–15.
97. Cardo DM, Culver DH, Ciesielski CA, et al, Centers for Disease Control and Prevention Needlestick Surveillance Group. A case-control
    study of HIV seroconversion in health care workers after percutaneous
    exposure. N Engl J Med 1997;337:1485–90.
98. Beltrami EM. The risk and prevention of occupational human immunodeficiency virus infection. Seminars in Infection Control 2001;1:2–18.
99. CDC. National Institute for Occupational Safety and Health. NIOSH
    alert: Preventing needlestick injuries in health care settings. Cincinnati, OH: US Department of Health and Human Services, Public
    Health Service, CDC, National Institute for Occupational Safety and
    Health, 1999.
100. Klein RS, Phelan JA, Freeman K, et al. Low occupational risk of
     human immunodeficiency virus infection among dental professionals.
     N Engl J Med 1988;318:86–90.
101. Gruninger SE, Siew C, Chang SB, et al. Human immunodeficiency
     virus type I: infection among dentists. J Am Dent Assoc 1992;123:59–64.
102. Siew C, Gruninger SE, Miaw CL, Neidle EA. Percutaneous injuries in
     practicing dentists: a propective study using a 20-day diary. J Am Dent
     Assoc 1995;126:1227–34.
103. Cleveland JL, Lockwood SA, Gooch BF, et al. Percutaneous injuries in
     dentistry: an observational study. J Am Dent Assoc 1995;126:745–51.
104. Ramos-Gomez F, Ellison J, Greenspan D, Bird W, Lowe S, Gerberding
     JL. Accidental exposures to blood and body fluids among health care
     workers in dental teaching clinics: a prospective study. J Am Dent Assoc
     1997;128:1253–61.
105. Cleveland JL, Gooch BF, Lockwood SA. Occupational blood exposure
     in dentistry: a decade in review. Infect Control Hosp Epidemiol 1997;
     18:717–21.
106. Gooch BF, Siew C, Cleveland JL, Gruninger SE, Lockwood SA, Joy
     ED. Occupational blood exposure and HIV infection among oral and
     maxillofacial surgeons. Oral Surg Oral Med Oral Pathol Oral Radiol
     Endod 1998;85:128–34.
107. Gooch BF, Cardo DM, Marcus R, et al. Percutaneous exposures to
     HIV–infected blood among dental workers enrolled in the CDC
     needlestick study. J Am Dent Assoc 1995;126:1237–42.
108. Younai FS, Murphy DC, Kotelchuck D. Occupational exposures to
     blood in a dental teaching environment: results of a ten-year surveillance study. J Dent Educ 2001;65:436–8.
109. Carlton JE, Dodson TB, Cleveland JL, Lockwood SA. Percutaneous
     injuries during oral and maxillofacial surgery procedures. J Oral
     Maxillofac Surg 1997;55:553–6.
110. Harte J, Davis R, Plamondon T, Richardson B. The influence of dental unit design on percutaneous injury. J Am Dent Assoc 1998;
     129:1725–31.
111. US Department of Labor, Occupational Health and Safety Administration. 29 CFR Part 1910. Occupational exposure to bloodborne
     pathogens; needlesticks and other sharps injuries, final rule. Federal
     Register 2001;66:5325.
112. CDC. Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy procedures—
     Minneapolis-St. Paul, New York City, and San Francisco, 1993–1995.
     MMWR 1997;46:21–5.
113. CDC. Evaluation of blunt suture needles in preventing percutaneous
     injuries among health-care workers during gynecologic surgical procedures—New York City, March 1993–June 1994. MMWR 1997;
     46:25–9.
114. Mendelson MH, Lin-Chen BY, Solomon R, Bailey E, Kogan G,
     Goldbold J. Evaluation of a safety resheathable winged steel needle for
     prevention of percutaneous injuries associated with intravascularaccess procedures among healthcare workers. Infect Control Hosp
     Epidemiol 2003;24:105–12.
115. CDC. Recommendations for prevention of HIV transmission in healthcare settings. MMWR 1987;36(No. S2).
116. CDC. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety
     workers: a response to P.L. 100-607. The Health Omnibus Programs
     Extension Act of 1988. MMWR 1989;38(No. S6).
117. CDC. National Institute for Occupational Safety and Health. Selecting, evaluating, and using sharps disposal containers. Cincinnati, OH:
     US Department of Health and Human Services, Public Health Service, CDC, National Institute for Occupational Safety and Health,
118. DHHS publication no. (NIOSH) 97-111.
119. CDC. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR 1990;39
     (No. RR-1).
120. CDC. Notice to readers update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to
     HIV. MMWR 1996;45:468–72.
121. CDC. Public Health Service guidelines for the management of healthcare worker exposures to HIV and recommendations for postexposure
     prophylaxis. MMWR 1998;47(No. RR-7).
122. CDC. Recommendations for prevention and control of hepatitis C
     virus (HCV) infection and HCV-related chronic disease. MMWR
     1998;47(No. RR-19).
123. Steere AC, Mallison GF. Handwashing practices for the prevention of
     nosocomial infections. Ann Intern Med 1975;83:683–90.
124. Garner JS. CDC guideline for prevention of surgical wound infections, 1985. Supersedes guideline for prevention of surgical wound
     infections published in 1982. (Originally published in November
     1985). Revised. Infect Control 1986;7:193–200.
125. Larson EL. APIC guideline for hand washing and hand antisepsis in
     health-care settings. Am J Infect Control 1995;23:251–69.
126. CDC. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task
     Force. MMWR 2002;51(No. RR-16).
127. Casewell M, Phillips I. Hands as route of transmission for Klebsiella
     species. Br Med J 1977;2:1315–7.
128. Larson EL, Early E, Cloonan P, Sugrue S, Parides M. An organizational climate intervention associated with increased handwashing and
     decreased nosocomial infections. Behav Med 2000;26:14–22.
     52 MMWR December 19, 2003
129. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospitalwide programme to improve compliance with hand hygiene. Lancet
     2000;356:1307–12.
130. Price PB. New studies in surgical bacteriology and surgical technique.
     JAMA 1938;111:1993–6.
131. Dewar NE, Gravens DL. Effectiveness of septisol antiseptic foam as a
     surgical scrub agent. Appl Microbiol 1973;26:544–9.
132. Lowbury EJ, Lilly HA. Disinfection of the hands of surgeons and nurses.
     Br Med J 1960;1445–50.
133. Rotter M. Hand washing and hand disinfection. In: Mayhall CG, ed.
     Hospital epidemiology and infection control. 2nd ed. Philadelphia, PA:
     Lippincott Williams & Wilkins, 1999:1339–55.
134. Widmer AF. Replace hand washing with use of a waterless alcohol hand
     rub? Clin Infect Dis 2000;31:136–43.
135. Larson EL, Butz AM, Gullette DL, Laughon BA. Alcohol for surgical
     scrubbing? Infect Control Hosp Epidemiol 1990;11:139–43.
136. Faoagali J, Fong J, George N, Mahoney P, O’Rouke V. Comparison of
     the immediate, residual, and cumulative antibacterial effects of
     Novaderm R,* Novascrub R,* Betadine Surgical Scrub, Hibiclens, and
     liquid soap. Am J Infect Control 1995;23:337–43.
137. Association of Perioperative Registered Nurses. Recommended practices for sterilization in the practice setting. In: Fogg D, Parker N,
     Shevlin D, eds. 2002 standards, recommended practices, and guidelines. Denver, CO: AORN, 2002:333–42.
138. US Department Of Health and Human Services, Food and Drug
     Administration. Tentative final monograph for healthcare antiseptic
     drug products; proposed rule. Federal Register 1994;59:31441–52.
139. Larson E. A causal link between handwashing and risk of infection?
     Examination of the evidence. Infection Control.1988;9:28–36.
140. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Hospital
     Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol
     1999;20:250–78.
141. Doebbeling BN, Pfaller MA, Houston AK, Wenzel RP. Removal of
     nosocomial pathogens from the contaminated glove. Ann Intern Med
     1988;109:394–8.
142. Kabara JJ, Brady MB. Contamination of bar soaps under “in-use” conditions. J Environ Pathol Toxicol Oncol 1984;5:1–14.
143. Ojajärvi J. The importance of soap selection for routine hand hygiene
     in hospital. J Hyg (Lond) 1981;86:275–83.
144. Larson E, Leyden JJ, McGinley KJ, Grove GL, Talbot GH. Physiologic
     and microbiologic changes in skin related to frequent handwashing.
     Infect Control 1986;7:59–63.
145. Larson E. Handwashing: it’s essential—even when you use gloves. Am
     J Nurs 1989;89:934–9.
146. Field EA, McGowan P, Pearce PK, Martin MV. Rings and watches:
     should they be removed prior to operative dental procedures? J Dent
     1996;24:65–9.
147. Hobson DW, Woller W, Anderson L, Guthery E. Development and
     evaluation of a new alcohol-based surgical hand scrub formulation with
     persistent antimicrobial characteristics and brushless application. Am
     J Infect Control 1998;26:507–12.
148. Mulberry G, Snyder AT, Heilman J, Pyrek J, Stahl J. Evaluation of a
     waterless, scrubless chlorhexidine gluconate/ethanol surgical scrub for
     antimicrobial efficacy. Am J Infect Control 2001;29:377–82.
149. Association of Perioperative Registered Nurses. Recommended practices for surgical hand scrubs. In: Fogg D, Parker N, eds. 2003 standards, recommended practices, and guidelines. Denver, CO: AORN,
     Inc., 2003:277–80.
150. Larson E, Killien M. Factors influencing handwashing behavior of
     patient care personnel. Am J Infect Control 1982;10:93–9.
151. Zimakoff J, Kjelsberg AB, Larson SO, Holstein B. A multicenter questionnaire investigation of attitudes toward hand hygiene, assessed by
     the staff in fifteen hospitals in Denmark and Norway. Am J Infec Control 1992;20:58–64.
152. Grohskopf LA, Roth VR, Feikin DR, et al. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med 2001;344:1491–7.
153. Archibald LK, Corl A, Shah B, et al. Serratia marcescens outbreak associated with extrinsic contamination of 1% chlorxylenol soap. Infect
     Control Hosp Epidemiol 1997;18:704–9.
154. Larson EL, Norton Hughes CA, Pyrak JD, Sparks SM, Cagatay EU,
     Bartkus JM. Changes in bacterial flora associated with skin damage on
     hands of health care personnel. Am J Infect Control 1998;26:513–21.
155. Ojajärvi J, Mäkelä P, Rantasalo I. Failure of hand disinfection with
     frequent hand washing: a need for prolonged field studies. J Hyg (Lond)
     1977;79:107–19.
156. Berndt U, Wigger-Alberti W, Gabard B, Elsner P. Efficacy of a barrier
     cream and its vehicle as protective measures against occupational irritant contact dermatitis. Contact Dermatitis 2000;42:77–80.
157. McCormick RD, Buchman TL, Maki DG. Double-blind, randomized
     trial of scheduled use of a novel barrier cream and an oil-containing
     lotion for protecting the hands of health care workers. Am J Infect
     Control 2000;28:302–10.
158. Larson E, Anderson JK, Baxendale L, Bobo L. Effects of a protective
     foam on scrubbing and gloving. Am J Infect Control 1993;21:297–301.
159. McGinley KJ, Larson EL, Leyden JJ. Composition and density of
     microflora in the subungual space of the hand. J Clin Microbiol
     1988;26:950–3.
     157 Pottinger J, Burns S, Manske C. Bacterial carriage by artificial versus
     natural nails. Am J Infect Control 1989;17:340–4.
160. McNeil SA, Foster CL, Hedderwick SA, Kauffman CA. Effect of hand
     cleansing with antimicrobial soap or alcohol-based gel on microbial
     colonization of artificial fingernails worn by health care workers. Clin
     Infect Dis 2001;32:367–72.
161. Rubin DM. Prosthetic fingernails in the OR: a research study. AORN
     J 1988;47:944–5.
162. Hedderwick SA, McNeil SA, Lyons MJ, Kauffman CA. Pathogenic
     organisms associated with artificial fingernails worn by healthcare workers. Infect Control Hosp Epidemiol 2000;21:505–9.
163. Passaro DJ, Waring L, Armstrong R, et al. Postoperative Serratia marcescens
     wound infections traced to an out-of-hospital source. J Infect Dis
     1997;175:992–5.
164. Foca M, Jakob K, Whittier S, et al. Endemic Pseudomonas aeruginosa
     infection in a neonatal intensive care unit. N Engl J Med 2000;
     343:695–700.
165. Parry MF, Grant B, Yukna M, et al. Candida osteomyelitis and diskitis
     after spinal surgery: an outbreak that implicates artificial nail use. Clin
     Infect Dis 2001;32:352–7.
166. Moolenaar RL, Crutcher M, San Joaquin VH, et al. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did
     staff fingernails play a role in disease transmission? Infect Control Hosp
     Epidemiol 2000;21:80–5.
167. Baumgardner CA, Maragos CS, Walz J, Larson E. Effects of nail polish
     on microbial growth of fingernails: dispelling sacred cows. AORN J
     1993;58:84–8.
     Vol. 52 / RR-17 Recommendations and Reports 53
168. Wynd CA, Samstag DE, Lapp AM. Bacterial carriage on the fingernails of OR nurses. AORN J 1994;60:796, 799–805.
169. Lowbury EJ. Aseptic methods in the operating suite. Lancet
     1968;1:705–9.
170. Hoffman PN, Cooke EM, McCarville MR, Emmerson AM. Microorganisms isolated from skin under wedding rings worn by hospital
     staff. Br Med J 1985;290:206–7.
171. Jacobson G, Thiele JE, McCune JH, Farrell LD. Handwashing: ringwearing and number of microorganisms. Nurs Res 1985;34:186–8.
172. Trick WE, Vernon MO, Hayes RA, et al. Impact of ring wearing on
     hand contamination and comparison of hand hygiene agents in a hospital. Clin Infect Dis 2003; 36:1383–90.
173. Salisbury DM, Hutfilz P, Treen LM, Bollin GE, Gautam S. The effect
     of rings on microbial load of health care workers’ hands. Am J Infec
     Control 1997;25:24–7.
174. Cochran MA, Miller CH, Sheldrake MS. The efficacy of the rubber
     dam as a barrier to the spread of microorganisms during dental treatment. J Am Dent Assoc 1989;119:141–4.
175. Miller CH, Palenik DJ. Aseptic techniques [Chapter 10]. In: Miller
     CH, Palenik DJ, eds. Infection control and management of hazardous
     materials for the dental team. 2nd ed. St. Louis, MO: Mosby, 1998.
176. CDC. National Institute for Occupational Safety and Health. TB respiratory protection program in health care facilities: administrator’s
     guide. Cincinnati, OH: US Department of Health and Human Services, Public Health Service, CDC, National Institute for Occupational
     Safety and Health, 1999. DHHS publication no. (NIOSH) 99-143.
177. US Department of Labor, Occupational Safety and Health Administration. OSHA 29 CFR 1910.139. Respiratory protection for
     M. tuberculosis. Federal Register 1998;49:442–9.
178. CDC. National Institute for Occupational Safety and Health. NIOSH
     guide to the selection and use of particulate respirators certified under
     42 CFR 84. Cincinnati, OH: US Department of Health and Human
     Services, Public Health Service, CDC, National Institute for Occupational Safety and Health, 1996. DHHS publication no. (NIOSH) 96-
     101.
179. DeGroot-Kosolcharoen J, Jones JM. Permeability of latex and vinyl
     gloves to water and blood. Am J Infect Control 1989;17:196–201.
180. Korniewicz DM, Laughon BE, Butz A, Larson E. Integrity of vinyl
     and latex procedure gloves. Nurs Res 1989;38:144–6.
181. Olsen RJ, Lynch P, Coyle MB, Cummings J, Bokete T, Stamm WE.
     Examination gloves as barriers to hand contamination in clinical practice. JAMA 1993;270:350–3.
182. Murray CA, Burke FJ, McHugh S. An assessment of the incidence of
     punctures in latex and non-latex dental examination gloves in routine
     clinical practice. Br Dent J 2001;190:377–80.
183. Burke FJ, Baggett FJ, Lomax AM. Assessment of the risk of glove puncture during oral surgery procedures. Oral Surg Oral Med Oral Pathol
     Oral Radiol Endod 1996;82:18–21.
184. Burke FJ, Wilson NH. The incidence of undiagnosed punctures in
     non-sterile gloves. Br Dent J 1990;168:67–71.
185. Nikawa H, Hamada T, Tamamoto M, Abekura H. Perforation and
     proteinaceous contamination of dental gloves during prosthodontic
     treatments. Int J Prosthodont 1994;7:559–66.
186. Nikawa H, Hamada T, Tamamoto M, Abekura H, Murata H. Perforation of dental gloves during prosthodontic treatments as assessed by
     the conductivity and water inflation tests. Int J Prosthodont
     1996;9:362–6.
187. Avery CM, Hjort A, Walsh S, Johnson PA. Glove perforation during
     surgical extraction of wisdom teeth. Oral Surg Oral Med Oral Pathol
     Oral Radiol Endod 1998;86:23–5.
188. Otis LL, Cottone JA. Prevalence of perforations in disposable latex
     gloves during routine dental treatment. J Am Dent Assoc 1989;
     118:321–4.
189. Kotilainen HR, Brinker JP, Avato JL, Gantz NM. Latex and vinyl
     examination gloves. Quality control procedures and implications for
     health care workers. Arch Intern Med 1989;149:2749–53.
190. Food and Drug Administration. Glove powder report. Rockville, MD:
     US Department of Health and Human Services, Food and Drug
     Administration, 1997. Available at http://www.fda.gov/cdrh/glvpwd.html.
191. Morgan DJ, Adams D. Permeability studies on protective gloves used
     in dental practice. Br Dent J 1989;166:11–3.
192. Albin MS, Bunegin L, Duke ES, Ritter RR, Page CP. Anatomy of a
     defective barrier: sequential glove leak detection in a surgical and dental environment. Crit Care Med 1992;20:170–84.
193. Merchant VA, Molinari JA, Pickett T. Microbial penetration of gloves
     following usage in routine dental procedures. Am J Dent 1992;5:95–6.
194. Pitten FA, Herdemann G, Kramer A. The integrity of latex gloves in
     clinical dental practice. Infection 2000;28:388–92.
195. Jamal A, Wilkinson S. The mechanical and microbiological integrity
     of surgical gloves. ANZ J Surg 2003;73:140–3.
196. Korniewicz DM, El-Masri MM, Broyles JM, Martin CD, O’Connell
     KP. A laboratory-based study to assess the performance of surgical gloves.
     AORN J 2003;77:772–9.
197. Schwimmer A, Massoumi M, Barr CE. Efficacy of double gloving to
     prevent inner glove perforation during outpatient oral surgical procedures. J Am Dent Assoc 1994;125:196–8.
198. Patton LL, Campbell TL, Evers SP. Prevalence of glove perforations during double-gloving for dental procedures. Gen Dent 1995;43:22–6.
199. Gerberding JL, Littell C, Tarkington A, Brown A, Schecter WP. Risk
     of exposure of surgical personnel to patients’ blood during surgery at
     San Francisco General Hospital. N Engl J Med 1990;322:1788–93.
200. Klein RC, Party E, Gershey EL. Virus penetration of examination gloves.
     Biotechniques 1990;9:196–9.
201. Mellstrom GA, Lindberg M, Boman A. Permeation and destructive
     effects of disinfectants on protective gloves. Contact Dermatitis
     1992;26:163–70.
202. Jordan SL, Stowers MF, Trawick EG, Theis AB. Glutaraldehyde permeation: choosing the proper glove. Am J Infect Control 1996;24:67–9.
203. Cappuccio WR, Lees PS, Breysse PN, Margolick JB. Evaluation of
     integrity of gloves used in a flow cytometry laboratory. Infect Control
     Hosp Epidemiol 1997;18:423–5.
204. Monticello MV, Gaber DJ. Glove resistance to permeation by a 7.5%
     hydrogen peroxide sterilizing and disinfecting solution. Am J Infec
     Control 1999;27:364–6.
205. Baumann MA, Rath B, Fischer JH, Iffland R. The permeability of
     dental procedure and examination gloves by an alcohol based disinfectant. Dent Mater 2000;16:139–44.
206. Ready MA, Schuster GS, Wilson JT, Hanes CM. Effects of dental
     medicaments on examination glove permeability. J Prosthet Dent
     1989;61:499–503.
207. Richards JM, Sydiskis RJ, Davidson WM, Josell SD, Lavine DS. Permeability of latex gloves after contact with dental materials. Am
     J Orthod Dentofacial Orthop 1993;104:224–9.
     54 MMWR December 19, 2003
208. Andersson T, Bruze M, Bjorkner B. In vivo testing of the protection of
     gloves against acrylates in dentin-bonding systems on patients with known
     contact allergy to acrylates. Contact Dermatitis 1999;41:254–9.
209. Reitz CD, Clark NP. The setting of vinyl polysiloxane and condensation silicone putties when mixed with gloved hands. J Am Dent Assoc
     1988;116:371–5.
210. Kahn RL, Donovan TE, Chee WW. Interaction of gloves and rubber
     dam with a poly (vinyl siloxane) impression material: a screening test.
     Int J Prosthodont 1989;2:342–6.
211. Matis BA, Valadez D, Valadez E. The effect of the use of dental gloves
     on mixing vinyl polysiloxane putties. J Prosthodont 1997;6:189–92.
212. Wright JG, McGeer AJ, Chyatte D, Ransohoff DF. Mechanisms of
     glove tears and sharp injuries among surgical personnel. JAMA
     1991;266:1668–71.
213. Dodds RD, Guy PJ, Peacock AM, Duffy SR, Barker SG, Thomas MH.
     Surgical glove perforation. Br J Surg 1988;75:966–8.
214. Adams D, Bagg J, Limaye M, Parsons K, Absi EG. A clinical evaluation of glove washing and re-use in dental practice. J Hosp Infect
     1992;20:153–62.
215. Martin MV, Dunn HM, Field EA, et al. A physical and microbiological
     evaluation of the re-use of non-sterile gloves. Br Dent J 1988;165:321–4.
216. US Department of Health and Human Services, Food and Drug
     Administration. 21 CFR Part 800. Medical devices; patient examination and surgeon’s gloves. Adulteration, final rule. Federal Register
     1990;55:51254–8.
217. Giglio JA, Roland RW, Laskin DM, Grenevicki L. The use of sterile
     versus nonsterile gloves during out-patient exodontia. Quintessence
     Int 1993;24:543–5.
218. Cheung LK, Chow LK, Tsang MH, Tung LK. An evaluation of complications following dental extractions using either sterile or clean gloves.
     Int J Oral Maxillofac Surg 2001;30:550–4.
219. Gani JS, Anseline PF, Bissett RL. Efficacy of double versus single gloving in protecting the operating team. Aust N Z J Surg 1990;60:171–5.
220. Short LJ, Bell DM. Risk of occupational infection with blood-borne
     pathogens in operating and delivery room settings. Am J Infect Control 1993;21:343–50.
221. Tokars JI, Culver DH, Mendelson MH, et al. Skin and mucous membrane contacts with blood during surgical procedures: risk and prevention. Infect Control Hosp Epidemiol 1995;16:703–11.
222. Tanner J, Parkinson H. Double gloving to reduce surgical crossinfection (Cochrane Review). The Cochrane Library 2003;(Issue 2):1–32.
223. Webb JM, Pentlow BD. Double gloving and surgical technique. Ann
     R Coll Surg Engl 1993;75:291–2.
224. Watts D, Tassler PL, Dellon AL. The effect of double gloving on cutaneous sensibility, skin compliance and suture identification. Contemp
     Surg 1994;44:289–92.
225. Wilson SJ, Sellu D, Uy A, Jaffer MA. Subjective effects of double gloves
     on surgical performance. Ann R Coll Surg Engl 1996;78:20–2.
226. Food and Drug Administration. Guidance for industry and FDA:
     medical glove guidance manual [Draft guidance]. Rockville, MD:
     US Department of Health and Human Services, Food and Drug
     Administration, 1999. Available at http://www.fda.gov/cdrh/dsma/
     135.html#_Toc458914315.
227. Dillard SF, Hefflin B, Kaczmarek RG, Petsonk EL, Gross TP. Health
     effects associated with medical glove use. AORN J 2002;76:88–96.
228. Hamann CP, Turjanmaa K, Rietschel R, et al. Natural rubber latex
     hypersensitivity: incidence and prevalence of type I allergy in the dental professional. J Am Dent Assoc 1998;129:43–54.
229. Siew C, Hamann C, Gruninger SE, Rodgers P, Sullivan KM. 2003.Type
     I Latex Allergic Reactions among Dental Professionals, 1996–2001.
     Journal of Dental Research, 82 (Special Issue): #1718.
230. Saary MJ, Kanani A, Alghadeer H, Holness DL, Tarlo SM. Changes in
     rates of natural rubber latex sensitivity among dental school students
     and staff members after changes in latex gloves. J Allergy Clin Immunol
     2002;109:131–5.
231. Hunt LW, Kelkar P, Reed CE, Yunginger JW. Management of occupational allergy to natural rubber latex in a medical center: the importance of quantitative latex allergen measurement and objective
     follow-up. J Allergy Clin Immunol 2002; 110(suppl 2):S96–106.
232. Turjanmaa K, Kanto M, Kautiainen H, Reunala T, Palosuo T. Longterm outcome of 160 adult patients with natural rubber latex allergy.
     J Allergy Clin Immunol 2002; 110(suppl 2):S70–4.
233. Heilman DK, Jones RT, Swanson MC, Yunginger JW. A prospective,
     controlled study showing that rubber gloves are the major contributor
     to latex aeroallergen levels in the operating room. J Allergy Clin
     Immunol 1996;98:325–30.
234. Baur X, Jager D. Airborne antigens from latex gloves. Lancet 1990;
     335:912.
235. Turjanmaa K, Reunala T, Alenius H, Brummer-Korvenkontio H,
     Palosuo T. Allergens in latex surgical gloves and glove powder. Lancet
     1990;336:1588.
236. Baur X, Chen Z, Allmers H. Can a threshold limit value for natural
     rubber latex airborne allergens be defined? J Allergy Clin Immunol
     1998;101:24–7.
237. Trape M, Schenck P, Warren A. Latex gloves use and symptoms in
     health care workers 1 year after implementaion of a policy restricting
     the use of powdered gloves. Am J Infec Control 2000;28:352–8.
238. Allmers H, Brehler R, Chen Z, Raulf-Heimsoth M, Fels H, Baur X.
     Reduction of latex aeroallergens and latex-specific IgE antibodies in
     sensitized workers after removal of powdered natural rubber latex gloves
     in a hospital. Allergy Clin Immunol 1998;102:841–6.
239. Tarlo SM, Sussman G, Contala A, Swanson MC. Control of airborne
     latex by use of powder-free latex gloves. J Allergy Clin Immunol
     1994;93:985–9.
240. Swanson MC, Bubak ME, Hunt LW, Yunginger JW, Warner MA, Reed
     CE. Quantification of occupational latex aeroallergens in a medical
     center. J Allergy Clin Immunol 1994;94:445–551.
241. Hermesch CB, Spackman GK, Dodge WW, Salazar A. Effect of
     powder-free latex examination glove use on airborne powder levels in a
     dental school clinic. J Dent Educ 1999;63:814–20.
242. Miller CH. Infection control strategies for the dental office [Chapter
     29]. In: Ciancio SG, ed. ADA guide to dental therapeutics. 2nd ed.
     Chicago, IL: ADA Publishing, 2000:543–58.
243. Primeau MN, Adkinson NF Jr, Hamilton RG. Natural rubber pharmaceutical vial closures release latex allergens that produce skin reactions. J Allergy Clin Immunol 2001;107:958–62.
244. Spaulding EH. Chemical disinfection of medical and surgical materials [Chapter 32]. In: Lawrence CA, Block SS, eds. Disinfection, sterilization and preservation. Philadelphia, PA: Lea & Febiger, 1968:
     517–31.
245. CDC. Guideline for disinfection and sterilization in healthcare facilities: recommendations of CDC and the Healthcare Infection Control
     Practices Advisory Committee (HICPAC). MMWR (in press).
246. CDC. Guidelines for environmental infection control in health-care
     facilities: recommendations of CDC and the Healthcare Infection
     Control Practices Advisory Committee (HICPAC). MMWR
     2003;52(No. RR-10).
     Vol. 52 / RR-17 Recommendations and Reports 55
247. US Environmental Protection Agency. 40 CFR Parts 152, 156, and
248. Exemption of certain pesticide substances from federal insecticide, fungicide, and rodenticide act requirements. Amended 1996.
     Federal Register 1996;61:8876–9.
249. Food and Drug Administration. Dental handpiece sterilization [Letter]. Rockville, MD: US Department of Health and Human Services,
     Food and Drug Administration, 1992.
250. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Steam sterilization and sterility
     assurance in health care facilities. ANSI/AAMI ST46-2002. Arlington, VA: Association for the Advancement of Medical Instrumentation, 2002.
251. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Steam sterilization and sterility
     assurance using table-top sterilizers in office-based, ambulatory-care
     medical, surgical, and dental facilities. ANSI/AAMI ST40-1998.
     Arlington, VA: Association for the Advancement of Medical Instrumentation, 1998.
252. Favero MS, Bond WW. Chemical disinfection of medical and surgical
     material [Chapter 43]. In: Block SS, ed. Disinfection, sterilization and
     preservation. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins,
     2001:881–917.
253. Parker HH 4th, Johnson RB. Effectiveness of ethylene oxide for sterilization of dental handpieces. J Dent 1995;23:113–5.
254. Alfa MJ, Olson N, Degagne P, Hizon R. New low temperature sterilization technologies: microbicidal activity and clinical efficacy [Chapter 9]. In: Rutala WA, ed. Disinfection, sterilization, and antisepsis in
     health-care. Champlain, NY: Polyscience Publications, 1998:67–78.
255. Rutala WA, Weber DJ. Clinical effectiveness of low-temperature
     sterilization technologies. Infect Control Hosp Epidemiol 1998;
     19:798–804.
256. Miller CH, Tan CM, Beiswanger MA, Gaines DJ, Setcos JC, Palenik
     CJ. Cleaning dental instruments: measuring the effectiveness of an
     instrument washer/disinfector. Am J Dent 2000;13:39–43.
257. Association for the Advancement of Medical Instrumentation. Chemical indicators—guidance for the selection, use, and interpretation of
     results. AAMI Technical Information Report No. 25. Arlington, VA:
     Association for the Advancement of Medical Instrumentation, 1999.
258. Ninemeier J. Central service technical manual. 5th ed. Chicago, IL:
     International Association of Healthcare Central Service Materiel Management, 1998.
259. Rutala WA, Weber DJ. Choosing a sterilization wrap for surgical packs.
     Infection Control Today 2000;4:64,70.
260. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Good hospital practice: steam sterilization and sterility assurance. ANSI/AAMI ST46-1993. Arlington, VA:
     Association for the Advancement of Medical Instrumentation, 1993.
261. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Flash sterilization: steam sterilization of patient care items for immediate use. ANSI/AAMI ST37-1996.
     Arlington, VA: Association for the Advancement of Medical Instrumentation, 1996.
262. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Ethylene oxide sterilization in health
     care facilities: safety and effectiveness. ANSI/AAMI ST41-1999.
     Arlington, VA: Association for the Advancement of Medical Instrumentation, 1999.
263. Miller CH, Palenik CJ. Sterilization, disinfection, and asepsis in dentistry [Chapter 53]. In: Block SS, ed. 5th ed. Disinfection, sterilization, and preservation. Philadelphia, PA: Lippincott Williams &
     Wilkins, 2001:1049–68.
264. Joslyn LJ. Sterilization by heat [Chapter 36]. In: Block SS, ed. 5th ed.
     Disinfection, sterilization, and preservation. Philadelphia, PA:
     Lippincott Williams & Wilkins, 2001:695–728.
265. Rutala WA, Weber DJ, Chappell KJ. Patient injury from flashsterilized instruments. Infect Control Hosp Epidemiol 1999;20:458.
266. Bond WW. Biological indicators for a liquid chemical sterilizer: a solution to the instrument reprocessing problem? Infect Control Hosp
     Epidemiol 1993;14:309–12.
267. Stingeni L, Lapomarda V, Lisi P. Occupational hand dermatitis in hospital environments. Contact Dermatitis 1995;33:172–6.
268. Ashdown BC, Stricof DD, May ML, Sherman SJ, Carmody RF.
     Hydrogen peroxide poisoning causing brain infarction: neuroimaging
     findings. Am J Roentgenol 1998;170:1653–5.
269. Ballantyne B. Toxicology of glutaraldehyde: review of studies and
     human health effects. Danbury, CT: Union Carbide, 1995.
270. CDC. National Institute for Occupational Safety and Health. Glutaraldehyde: occupational hazards in hospitals. Cincinnati, OH: US
     Department of Health and Human Services, Public Health Service,
     CDC, National Institute for Occupational Safety and Health, 2001.
     DHHS publication no. (NIOSH) 2001-115.
     268 CDC. Epidemiologic notes and reports: symptoms of irritation associated with exposure to glutaraldehyde—Colorado. MMWR
     1987;36:190–1.
271. Lehman PA, Franz TJ, Guin JD. Penetration of glutaraldehyde through
     glove material: tactylon versus natural rubber latex. Contact Dermatitis 1994;30:176–7.
272. Hamann CP, Rodgers PA, Sullivan K. Allergic contact dermatitis in
     dental professionals: effective diagnosis and treatment. J Am Dent Assoc
     2003;134:185–94.
273. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Safe use and handling of glutaraldehyde-based products in health care facilities. ANSI/AAMI ST58-1996.
     Arlington, VA: Association for the Advancement of Medical Instrumentation, 1996.
274. Fisher AA. Ethylene oxide dermatitis. Cutis 1984;34:20, 22, 24.
275. Jay WM, Swift TR, Hull DS. Possible relationship of ethylene oxide
     exposure to cataract formation. Am J Ophthalmol 1982;93:727–32.
276. US Department of Labor, Occupational Safety and Health Administration. Review of the ethylene oxide standard. Federal Register
     2000;65:35127–8.
277. Pratt LH, Smith DG, Thornton RH, Simmons JB, Depta BB, Johnson
     RB. The effectiveness of two sterilization methods when different
     precleaning techniques are employed. J Dent 1999;27:247–8.
278. US Department of Health and Human Services, Food and Drug
     Administration. 21 CFR Part 872.6730. Dental devices; endodontic
     dry heat sterilizer; final rule. Federal Register 1997;62:2903.
279. Favero MS. Current issues in hospital hygiene and sterilization technology. J Infect Control (Asia Pacific Edition) 1998;1:8–10.
280. Greene WW. Control of sterilization process [Chapter 22]. In: Russell
     AD, Hugo WB, Ayliffe GA, eds. Principles and practice of disinfection, preservation, and sterilization. Oxford, England: Blackwell Scientific Publications, 1992:605–24.
     56 MMWR December 19, 2003
281. Favero MS. Developing indicators for sterilization [Chapter 13]. In:
     Rutala W, ed. Disinfection, sterilization, and antisepsis in health care.
     Washington, DC: Association for Professionals in Infection Control
     and Epidemiology, Inc., 1998:119–32.
282. Maki DG, Hassemer CA. Flash sterilization: carefully measured haste.
     Infect Control 1987;8:307–10.
283. Andres MT, Tejerina JM, Fierro JF. Reliability of biologic indicators in
     a mail-return sterilization-monitoring service: a review of 3 years.
     Quintessence Int 1995;26:865–70.
284. Miller CH, Sheldrake MA. The ability of biological indicators to
     detect sterilization failures. Am J Dent 1994;7:95–7.
285. Association of Operating Room Nurses. AORN standards and recommended practices for perioperative nursing. Denver, CO: AORN, 1987.
286. Mayworm D. Sterile shelf life and expiration dating. J Hosp Supply
     Process Distrib 1984;2:32–5.
287. Cardo DM, Sehulster LM. Central sterile supply [Chapter 65]. In:
     Mayhall CG, ed. Hospital Epidemiology and Infection Control. 2nd
     ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1999:1023–30.
288. Maki DG, Alvarado CJ, Hassemer CA, Zilz MA. Relation of the
     inanimate hospital environment to endemic nosocomial infection.
     N Engl J Med 1982;307:1562–6.
289. Danforth D, Nicolle LE, Hume K, Alfieri N, Sims H. Nosocomial
     infections on nursing units with floors cleaned with a disinfectant compared with detergent. J Hosp Infect 1987;10:229–35.
290. Crawford JJ. Clinical asepsis in dentistry. Mesquite, TX: Oral Medicine Press, 1987.
291. Food and Drug Administration. Design control guidance for medical
     device manufacturers. Rockville, MD: US Department of Health and
     Human Services, Food and Drug Administration, 1997.
292. Fauerbach LL, Janelle JW. Practical applications in infection control
     [Chapter 45]. In: Block SS, ed. 5th ed. Disinfection, sterilization, and
     preservation. Philadelphia, PA: Lippincott Williams & Wilkins,
     2001:935–44.
293. Martin LS, McDougal JS, Loskoski SL. Disinfection and inactivation
     of the human T lymphotrophic virus type III/lymphadenopathyassociated virus. J Infect Dis 1985;152:400–3.
294. Bloomfield SF, Smith-Burchnell CA, Dalgleish AG. Evaluation of
     hypochlorite-releasing disinfectants against the human immunodeficiency virus (HIV). J Hosp Infect 1990;15:273–8.
295. Gerson SL, Parker P, Jacobs MR, Creger R, Lazarus HM. Aspergillosis
     due to carpet contamination. Infect Control Hosp Epidemiol
     1994;15:221–3.
296. Suzuki A, Namba Y, Matsuura M, Horisawa A. Bacterial contamination of floors and other surfaces in operating rooms: a five–year survey.
     J Hyg (Lond) 1984;93:559–66.
297. Skoutelis AT, Westenfelder GO, Beckerdite M, Phair JP. Hospital carpeting and epidemiology of Clostridium difficile. Am J Infect Control
     1994;22:212–7.
298. Rutala WA, Odette RL, Samsa GP. Management of infectious waste
     by US hospitals. JAMA 1989;262:1635–40.
299. CDC. Perspectives in disease prevention and health promotion. Summary of the Agency for Toxic Substances and Disease Registry report
     to Congress: the public health implications of medical waste. MMWR
     1990; 39:822–4.
300. Palenik CJ. Managing regulated waste in dental environments.
     J Contemp Dent Pract 2003;4:76.
301. Rutala WA, Mayhall CG. Medical waste. Infect Control Hosp
     Edidemiol 1992;13:38–48.
302. Greene R, State and Territorial Association on Alternate Treatment
     Technologies. Technical assistance manual: state regulatory oversight
     of medical waste treatment technologies. 2nd ed. Washington, DC:
     US Environmental Protection Agency, 1994. Available at http://www.
     epa.gov/epaoswer/other/medical/mwpdfs/ta/1.pdf.
303. US Environmental Protection Agency. 40 CFR Part 60. Standards of
     performance for new stationary sources and emission guidelines for
     existing sources: hospital/medical/infectious waste incinerators; final
     rule. Federal Register 1997;62:48347–91.
304. Slade JS, Pike EB, Eglin RP, Colbourne JS, Kurtz JB. The survival of
     human immunodeficiency virus in water, sewage, and sea water. Water
     Sci Tech 1989;21:55–9.
305. Walker JT, Bradshaw DJ, Bennett AM, Fulford MR, Martin MV, Marsh
     PD. Microbial biofilm formation and contamination of dental-unit
     water systems in general dental practice. Appl Environ Microbiol
     2000;66:3363–7.
306. Schulze-Robbecke R, Feldmann C, Fischeder R, Janning B, Exner M,
     Wahl G. Dental units: an environmental study of sources of potentially pathogenic mycobacteria. Tuber Lung Dis 1995;76:318–23.
307. Barbeau J, Tanguay R, Faucher E, et al. Multiparametric analysis of
     waterline contamination in dental units. Appl Environ Microbiol
     1996;62:3954–9.
308. Atlas RM, Williams JF, Huntington MK. Legionella contamination of
     dental-unit waters. Appl Environ Microbiol 1995;61:1208–13.
309. Kelstrup J, Funder-Nielsen T, Theilade J. Microbial aggregate contamination of water lines in dental equipment and its control. Acta Pathol
     Microbiol Scand [B] 1977;85:177–83.
310. Challacombe SJ, Fernandes LL. Detecting Legionella pneumophila in
     water systems: a comparison of various dental units. J Am Dent Assoc
     1995;126:603–8.
311. Mayo JA, Oertling KM, Andrieu SC. Bacterial biofilm: a source of contamination in dental air-water syringes. Clin Prev Dent 1990;12:13–20.
312. Scheid RC, Kim CK, Bright JS, Whitely MS, Rosen S. Reduction of
     microbes in handpieces by flushing before use. J Am Dent Assoc
     1982;105:658–60.
313. Bagga BS, Murphy RA, Anderson AW, Punwani I. Contamination of
     dental unit cooling water with oral microorganisms and its prevention. J Am Dent Assoc 1984;109:712–6.
314. Martin MV. The significance of the bacterial contamination of dental
     unit water systems. Br Dent J 1987;163:152–4.
315. Pankhurst CL, Philpott-Howard JN, Hewitt JH, Casewell MW. The
     efficacy of chlorination and filtration in the control and eradication of
     Legionella from dental chair water systems. J Hosp Infect 1990;16:9–18.
316. Mills SE, Lauderdale PW, Mayhew RB. Reduction of microbial contamination in dental units with povidone-iodine 10%. J Am Dent
     Assoc 1986;113:280–4.
317. Williams JF, Johnston AM, Johnson B, Huntington MK, Mackenzie
     CD. Microbial contamination of dental unit waterlines: prevalence,
     intensity and microbiological characteristics. J Am Dent Assoc
     1993;124:59–65.
318. Mills SE. The dental unit waterline controversy: defusing the myths,
     defining the solutions. J Am Dent Assoc 2000;131:1427–41.
319. Jones F, Bartlett CL. Infections associated with whirlpools and spas.
     Soc Appl Bacteriol Symp Ser 1985;14:61S–6S.
320. Hollyoak V, Allison D, Summers J. Pseudomonas aeruginosa wound
     infection associated with a nursing home’s whirlpool bath. Commun
     Dis Rep CDR Rev 1995;5:R100–2.
     Vol. 52 / RR-17 Recommendations and Reports 57
321. Begg N, O’Mahony M, Penny P, Richardson EA, Basavaraj DS. Mycobacterium chelonei associated with a hospital hydrotherapy pool. Community Med 1986;8:348–50.
322. Laussucq S, Baltch AL, Smith RP, et al. Nosocomial Mycobacterium
     fortuitum colonization from a contaminated ice machine. Am Rev
     Respir Dis 1988;138:891–4.
323. Struelens MJ, Rost F, Deplano A, et al. Pseudomonas aeruginosa and
     Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak
     investigation using DNA macrorestriction analysis. Am J Med 1993;95:
     489–98.
324. Kuritsky JN, Bullen MG, Broome CV, Silcox VA, Good RC, Wallace RJ
     Jr. Sternal wound infections and endocarditis due to organisms of the
     Mycobacterium fortuitum complex. Ann Intern Med 1983;98:938–9.
325. Bolan G, Reingold AL, Carson LA, et al. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed
     hemodialyzers. J Infect Dis 1985;152:1013–9.
326. Lessing MP, Walker MM. Fatal pulmonary infection due to Mycobacterium fortuitum. J Clin Pathol 1993;46:271–2.
327. Arnow PM, Chou T, Weil D, Shapiro EN, Kretzschmar C. Nosocomial Legionnaires’ disease caused by aerosolized tap water from respiratory devices. J Infect Dis 1982;146:460–7.
328. Breiman RF, Fields BS, Sanden GN, Volmer L, Meier A, Spika JS.
     Association of shower use with Legionnaires’ disease: possible role of
     amoebae. JAMA 1990;263:2924–6.
329. Garbe PL, Davis BJ, Weisfeld JS, et al. Nosocomial Legionnaires’ disease: epidemiologic demonstration of cooling towers as a source. JAMA
     1985;254:521–4.
330. Fallon RJ, Rowbotham TJ. Microbiological investigations into an outbreak of Pontiac fever due to Legionella micdadei associated with use of
     a whirlpool. J Clin Pathol 1990;43:479–83.
331. Rose CS, Martyny JW, Newman LS, et al. “Lifeguard lung”: endemic
     granulomatous pneumonitis in an indoor swimming pool. Am J Public Health 1998;88:1795–1800.
332. CDC. Epidemiologic notes and reports: Legionnaires’ disease outbreak
     associated with a grocery store mist machine—Louisiana, 1989.
     MMWR 1990;39:108–10.
333. Jacobs RL, Thorner RE, Holcomb JR, Schwietz LA, Jacobs FO.
     Hypersensitivity pneumonitis caused by Cladosporium in an enclosed
     hot-tub area. Ann Intern Med 1986;105:204–6.
334. Clark A. Bacterial colonization of dental units and the nasal flora of
     dental personnel. Proc Roy Soc Med 1974;67:1269–70.
335. Fotos PG, Westfall HN, Snyder IS, Miller RW, Mutchler BM. Prevalence of Legionella-specific IgG and IgM antibody in a dental clinic
     population. J Dent Res 1985;64:1382–5.
336. Reinthaler FF, Mascher F, Stunzner D. Serological examinations for
     antibodies against Legionella species in dental personnel. J Dent Res
     1988;67:942–3.
337. Putnins EE, Di Giovanni D, Bhullar AS. Dental unit waterline contamination and its possible implications during periodontal surgery.
     J Periodontol 2001;72:393–400.
338. United States Pharmacopeial Convention. Sterile water for irrigation.
     In: United States Pharmacopeial Convention. United States pharmacopeia and national formulary. USP 24–NF 19. Rockville, MD: United
     States Pharmacopeial Convention, 1997:1753.
339. Milton DK, Wypij D, Kriebel D, Walters MD, Hammond SK, Evans
     JS. Endotoxin exposure-response in a fiberglass manufacturing facility. Am J Ind Med 1996;29:3–13.
340. Santiago JI. Microbial contamination of dental unit waterlines: short
     and long term effects of flushing. Gen Dent 1994;42:528–35.
341. Shearer BG. Biofilm and the dental office. J Am Dent Assoc 1996;
     127:181–9.
342. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Hemodialysis systems. ANSI/AAMI
     RD5-1992. Arlington, VA: Association for the Advancement of Medical Instrumentation, 1993.
343. US Environmental Protection Agency. National primary drinking water
     regulations, 1999: list of contaminants. Washington DC: US Environmental Protection Agency, 1999. Available at http://www.epa.gov/
     safewater/mcl.html.
344. American Public Health Association, American Water Works Association, Water Environment Foundation. In: Eaton AD, Clesceri LS,
     Greenberg AE, eds. Standard methods for the examination of water
     and wastewater. Washington, DC: American Public Health Association, 1999.
345. Williams HN, Johnson A, Kelley JI, et al. Bacterial contamination of
     the water supply in newly installed dental units. Quintessence Int
     1995;26:331–7.
346. Scheid RC, Rosen S, Beck FM. Reduction of CFUs in high-speed handpiece water lines over time. Clin Prev Dent 1990;12:9–12.
347. Williams HN, Kelley J, Folineo D, Williams GC, Hawley CL, Sibiski
     J. Assessing microbial contamination in clean water dental units and
     compliance with disinfection protocol. J Am Dent Assoc 1994;125:
     1205–11.
348. CDC, Working Group on Waterborne Cryptosporidiosis.
     Cryptosporidium and water: a public health handbook. Atlanta, GA:
     US Department of Health and Human Services, Public Health Service, CDC, 1997.
349. MacKenzie WR, Hoxie NJ, Proctor ME, et al. A massive outbreak in
     Milwaukee of cryptosporidium infection transmitted through the public
     water supply. N Engl J Med 1994;331:161–7.
350. Kaminski JC. Cryptosporidium and the public water supply. N Engl
     J Med 1994;331:1529–30.
351. CDC. Assessing the public health threat associated with waterborne
     cryptosporidiosis: report of a workshop. MMWR 1995;44(No. RR-6).
352. CDC. Surveillance for waterborne-disease outbreaks—United States,
     1993–1994. MMWR 1996;45(No. SS-1).
353. Office of Water, US Environmental Protection Agency. Lead and copper rule: summary of revisions. EPA 815–R–99–020. Washington DC:
     US Environmental Protection Agency, 2000.
354. US Environmental Protection Agency. 65 CFR Parts 141 and 142.
     National primary drinking water regulations for lead and copper, final
     rule. Federal Register 2000;1949–2015.
355. Gooch B, Marianos D, Ciesielski C, et al. Lack of evidence for patientto-patient transmission of HIV in a dental practice. J Am Dent Assoc
     1993;124:38–44.
356. Crawford JJ, Broderius C. Control of cross-infection risks in the dental operatory: preventon of water retraction by bur cooling spray systems. J Am Dent Assoc 1988;116:685–7.
357. Mills SE, Kuehne JC, Bradley DV Jr. Bacteriological analysis of highspeed handpiece turbines. J Am Dent Assoc 1993;124:59–62.
358. Lewis DL, Arens M, Appleton SS, et al. Cross-contamination potential with dental equipment. Lancet 1992;340:1252–4.
359. Lewis DL, Boe RK. Cross-infection risks associated with current procedures for using high-speed dental handpieces. J Clin Microbiol
     1992;30:401–6.
     58 MMWR December 19, 2003
360. Checchi L, Montebugnoli L, Samaritani S. Contamination of the turbine air chamber: a risk of cross infection. J Clin Periodontol
     1998;25:607–11.
361. Epstein JB, Rea G, Sibau L, Sherlock CH, Le ND. Assessing viral
     retention and elimination in rotary dental instruments. J Am Dent
     Assoc 1995;126:87–92.
362. Kolstad RA. How well does the chemiclave sterilize handpieces? J Am
     Dent Assoc 1998;129:985–91.
363. Kuehne JS, Cohen ME, Monroe SB. Performance and durability of
     autoclavable high-speed dental handpieces. NDRI-PR 92-03. Bethesda,
     MD: Naval Dental Research Institute, 1992.
364. Andersen HK, Fiehn NE, Larsen T. Effect of steam sterilization inside
     the turbine chambers of dental turbines. Oral Surg Oral Med Oral
     Pathol Oral Radiol Endod 1999;87:184–8.
365. Leonard DL, Charlton DG. Performance of high-speed dental
     handpieces subjected to simulated clinical use and sterilization. J Am
     Dent Assoc 1999;130:1301–11.
366. Barbeau J, ten Bokum L, Gauthier C, Prevost AP. Cross-contamination
     potential of saliva ejectors used in dentistry. J Hosp Infect 1998;
     40:303–11.
367. Mann GL, Campbell TL, Crawford JJ. Backflow in low-volume suction lines: the impact of pressure changes. J Am Dent Assoc
     1996;127:611–5.
368. Watson CM, Whitehouse RL. Possibility of cross-contamination
     between dental patients by means of the saliva ejector. J Am Dent Assoc
     1993;124:77–80.
369. Glass BJ, Terezhalmy GT. Infection control in dental radiology [Chapter
     15]. In: Cottone JA, Terezhalamy GT, Molinari JA, eds. Practical
     infection control in dentisty. 2nd ed. Baltimore. MD: Williams &
     Wilkins, 1996:229–38.
370. Haring JI, Jansen L. Infection control and the dental radiographer. In:
     Haring JI, Jansen L, eds. Dental radiography: principles and techniques.
     Philadelphia, PA: WB Saunders Co., 2000:194–204.
371. Hignett M, Claman P. High rates of perforation are found in
     endovaginal ultrasound probe covers before and after oocyte retrieval
     for in vitro fertilization-embryo transfer. J Assist Reprod Genet
     1995;12:606–9.
372. Fritz S, Hust MH, Ochs C, Gratwohl I, Staiger M, Braun B. Use of a
     latex cover sheath for transesophageal echocardiography (TEE) instead
     of regular disinfection of the echoscope? Clin Cardiol 1993;16:737–40.
373. Milki AA, Fisch JD. Vaginal ultrasound probe cover leakage: implications for patient care. Fertil Steril 1998;69:409–11.
374. Storment JM, Monga M, Blanco JD. Ineffectiveness of latex condoms
     in preventing contamination of the transvaginal ultrasound transducer
     head. South Med J 1997;90:206–8.
375. Amis S, Ruddy M, Kibbler CC, Economides DL, MacLean AB.
     Assessment of condoms as probe covers for transvaginal sonography.
     J Clin Ultrasound 2000;28:295–8.
376. Rooks VJ, Yancey MK, Elg SA, Brueske L. Comparison of probe sheaths
     for endovaginal sonography. Obstet Gynecol 1996;87:27–9.
377. Hokett SD, Honey JR, Ruiz F, Baisden MK, Hoen MM. Assessing the
     effectiveness of direct digital radiography barrier sheaths and finger
     cots. J Am Dent Assoc 2000;131:463–7.
378. ASHP Council on Professional Affairs. ASHP guidelines on quality
     assurance for pharmacy-prepared sterile products. Am J Health Syst
     Pharm 2000;57:1150–69.
379. Green KA, Mustachi B, Schoer K, Moro D, Blend R, McGeer A.
     Gadolinium-based MR contrast media: potential for growth of microbial contaminants when single vials are used for multiple patients.
     Am J Roentgenol 1995;165:669–71.
380. American Society of Anesthesiologists. Recommendations for infection control for the practice of anesthesiology. 2nd ed. Park Ridge,
     IL: American Society of Anesthesiologists,1999.
381. Henry B, Plante-Jenkins C, Ostrowska K. An outbreak of Serratia
     marcescens associated with the anesthetic agent propofol. Am J Infect
     Control 2001;29:312–5.
382. Plott RT, Wagner RF Jr, Tyring SK. Iatrogenic contamination of
     multidose vials in simulated use. A reassessment of current patient
     injection technique. Arch Dermatol 1990;126:1441–4.
383. Arrington ME, Gabbert KC, Mazgaj PW, Wolf MT. Multidose vial
     contamination in anesthesia. AANA J 1990;58:462–6.
384. CDC. Recommendations for preventing transmission of infections
     among chronic hemodialysis patients. MMWR 2001;50(No. RR-5).
385. Food and Drug Administration. Labeling recommendations for singleuse devices reprocessed by third parties and hospitals; final guidance
     for industry and FDA. Rockville, MD: US Department of Health and
     Human Services, Food and Drug Administration, 2001.
386. Villasenor A, Hill SD, Seale NS. Comparison of two ultrasonic cleaning units for deterioration of cutting edges and debris removal on dental burs. Pediatr Dent 1992;14:326–30.
387. Rapisarda E, Bonaccorso A, Tripi TR, Condorelli GG. Effect of sterilization on the cutting efficiency of rotary nickel-titanium endodontic files.
     Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:343–7.
388. Filho IB, Esberard RM, Leonardo R, del Rio CE. Microscopic evaluation of three endodontic files pre- and postinstrumentation. J Endodontics 1998;24:461–4.
389. Silvaggio J, Hicks ML. Effect of heat sterilization on the torsional properties of rotary nickel-titanium endodontic files. J Endodontics
     1997;23:731–4.
390. Kazemi RB, Stenman E, Spangberg LS. The endodontic file is a disposable instrument. J Endodontics 1995;21:451–5.
391. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial
     endocarditis: recommendations by the American Heart Association.
     JAMA 1990;264:2919–22.
392. Pallasch TJ, Slots J. Antibiotic prophylaxis and the medically compromised patient. Periodontology 2000 1996;10:107–38.
393. Litsky BY, Mascis JD, Litsky W. Use of an antimicrobial mouthwash
     to minimize the bacterial aerosol contamination generated by the highspeed drill. Oral Surg Oral Med Oral Pathol 1970;29:25–30.
394. Mohammed CI, Monserrate V. Preoperative oral rinsing as a means of
     reducing air contamination during use of air turbine handpieces. Oral
     Surg Oral Med Oral Pathol 1970;29:291–4.
395. Wyler D, Miller RL, Micik RE. Efficacy of self-administered preoperative oral hygiene procedures in reducing the concentration of bacteria in aerosols generated during dental procedures. J Dent Res
     1971;50:509.
396. Muir KF, Ross PW, MacPhee IT, Holbrook WP, Kowolik MJ. Reduction of microbial contamination from ultrasonic scalers. Br Dent
     J 1978;145:76–8.
397. Fine DH, Mendieta C, Barnett ML, et al. Efficacy of preprocedural
     rinsing with an antiseptic in reducing viable bacteria in dental aerosols. J Periodontol 1992;63:821–4.
398. Fine DH, Furgang D, Korik I, Olshan A, Barnett ML, Vincent JW.
     Reduction of viable bacteria in dental aerosols by preprocedural rinsing with an antiseptic mouthrinse. Am J Dent 1993;6:219–21.
     Vol. 52 / RR-17 Recommendations and Reports 59
399. Fine DH, Yip J, Furgang D, Barnett ML, Olshan AM, Vincent J.
     Reducing bacteria in dental aerosols: pre-procedural use of an antiseptic mouth rinse. J Am Dent Assoc 1993;124:56–8.
400. Logothetis DD, Martinez-Welles JM. Reducing bacterial aerosol contamination with a chlorhexidine gluconate pre-rinse. J Am Dent Assoc
     1995;126:1634–9.
401. Klyn SL, Cummings DE, Richardson BW, Davis RD. Reduction of
     bacteria-containing spray produced during ultrasonic scaling. Gen Dent
     2001;49:648–52.
402. Brown AR, Papasian CJ, Shultz P, Theisen FC, Shultz RE. Bacteremia
     and intraoral suture removal: can an antimicrobial rinse help? J Am
     Dent Assoc 1998;129:1455–61.
403. Lockhart PB. An analysis of bacteremias during dental extractions.
     A double-blind, placebo-controlled study of chlorhexidine. Arch
     Intern Med 1996;156:513–20.
404. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial
     endocarditis: recommendations by the American Heart Association.
     JAMA 1997;277:1794–1801.
405. Tate WH, White RR. Disinfection of human teeth for educational
     purposes. J Dent Educ 1991;55:583–5.
406. Pantera EA Jr, Zambon JJ, Shih-Levine M. Indirect immunofluorescence for the detection of Bacteroides species in human dental pulp.
     J Endodontics 1988;14:218–23.
407. Pantera EA Jr, Schuster GS. Sterilization of extracted human teeth.
     J Dent Educ 1990;54:283–5.
408. Parsell DE, Stewart BM, Barker JR, Nick TG, Karns L, Johnson RB.
     The effect of steam sterilization on the physical properties and perceived cutting characteristics of extracted teeth. J Dent Educ 1998;
     62;260–3.
409. American Dental Association’s Council on Scientific Affairs and Council on Dental Practice. Infection control recommendations for the dental
     office and the dental laboratory. J Am Dent Assoc 1996;127:672–80.
410. Dental Laboratory Relationship Working Group, Organization for
     Safety and Asepsis Procedures (OSAP). Laboratory asepsis position
     paper. Annapolis, MD: OSAP Foundation, 1998. Available at http://
     www.osap.org/issues/pages/position/LAB.pdf.
411. Kugel G, Perry RD, Ferrari M, Lalicata P. Disinfection and communication practices: a survey of U. S. dental laboratories. J Am Dent Assoc
     2000;131:786–92.
412. US Department of Transportation. 49 CFR 173.196 infectious substances (etiologic agents) 173.197 regulated medical waste. Available
     at http://www.access.gpo.gov/nara/cfr/waisidx_02/49cfr173_02.html.
413. Chau VB, Saunders TR, Pimsler M, Elfring DR. In-depth disinfection
     of acrylic resins. J Prosthet Dent 1995;74:309–13.
414. Powell GL, Runnells RD, Saxon BA, Whisenant BK. The presence
     and identification of organisms transmitted to dental laboratories.
     J Prosthet Dent 1990;64:235–7.
415. Giblin J, Podesta R, White J. Dimensional stability of impression
     materials immersed in an iodophor disinfectant. Int J Prosthodont
     1990;3:72–7.
416. Plummer KD, Wakefield CW. Practical infection control in dental laboratories. Gen Dent 1994;42:545–8.
417. Merchant VA. Infection control in the dental laboratory equipment
     [Chapter 16]. In: Cottone JA, Terezhalamy GT, Molinari JA, eds. Practical infection control in dentisty. 2nd ed. Baltimore, MD: Williams &
     Wilkins, 1996:239–54.
418. Molinari J. Dental. In: Association for Professionals in Infection Control and Epidemiology, Inc. (APIC). APIC text of infection control
     and epidemiology. Washington, DC: Association for Professionals in
     Infection Control and Epidemiology, Inc, 2002.
419. Sofou A, Larsen T, Fiehn NE, Owall B. Contamination level of alginate impressions arriving at a dental laboratory. Clin Oral Invest
     2002;6:161–5.
420. McNeill MR, Coulter WA, Hussey DL. Disinfection of irreversible
     hydrocolloid impressions: a comparative study. Int J Prosthodont
     1992;5:563–7.
421. Gerhardt DE, Sydiskis RJ. Impression materials and virus. J Am Dent
     Assoc 1991;122:51–4.
422. Leung RL, Schonfeld SE. Gypsum casts as a potential source of microbial cross-contamination. J Prosthet Dent 1983;49:210–1.
423. Huizing KL, Palenik CJ, Setcos JC, Sheldrake MA, Miller, CH. Method
     of evaluating the antimicrobial abilities of disinfectant-containing gypsum products. QDT Yearbook 1994;17:172–6.
424. Verran J, Kossar S, McCord JF. Microbiological study of selected risk
     areas in dental technology laboratories. J Dent 1996;24:77–80.
425. CDC. National Institute for Occupational Safety and Health. NIOSH
     Health Hazard Evaluation and Technical Assistance Report. Cincinnati, OH: US Department of Health and Human Services, Public
     Health Service, CDC, National Institute for Occupational Safety and
     Health, 1988. HETA 85-136-1932.
426. CDC. National Institute for Occupational Safety and Health. NIOSH
     Health Hazard Evaluation and Technical Assistance Report. Cincinnati, OH: US Department of Health and Human Services, Public
     Health Service, CDC, National Institute for Occupational Safety and
     Health, 1990. HETA 88-101-2008.
427. CDC. National Institute for Occupational Safety and Health. Control of smoke from laser/electric surgical procedures. Cincinnati, OH:
     US Department of Health and Human Services, Public Health Service, CDC, National Institute for Occupational Safety and Health,
428. DHHS publication no. (NIOSH) 96-128.
429. Taravella MJ, Weinberg A, Blackburn P, May M. Do intact viral particles
     survive excimer laser ablation? Arch Ophthalmol 1997;115:1028–30.
430. Hagen KB, Kettering JD, Aprecio RM, Beltran F, Maloney RK. Lack
     of virus transmission by the excimer laser plume. Am J Ophthalmol
     1997;124:206–11.
431. Kunachak S, Sithisarn P, Kulapaditharom B. Are laryngeal papilloma
     virus-infected cells viable in the plume derived from a continuous mode
     carbon dioxide laser, and are they infectious? A preliminary report on
     one laser mode. J Laryng Otol 1996;110:1031–3.
432. Hughes PS, Hughes AP. Absence of human papillomavirus DNA in
     the plume of erbium: YAG laser-treated warts. J Am Acad Dermatol
     1998;38:426–8.
433. Garden JM, O’Banion MK, Shelnitz LS, et al. Papillomavirus in the
     vapor of carbon dioxide laser-treated verrucae. JAMA 1988;259:
     1199–1202.
434. Sawchuk WS, Weber PJ, Lowry DR, Dzubow LM. Infectious
     papillomavirus in the vapor of warts treated with carbon dioxide laser
     or electrocoagulation: detection and protection. J Am Acad Dermatol
     1989;21:41–9.
435. Baggish MS, Poiesz BJ, Joret D, Williamson P, Rafai A. Presence of
     human immunodeficiency virus DNA in laser smoke. Lasers Surg Med
     1991;11:197–203.
436. Capizzi PJ, Clay RP, Battey MJ. Microbiologic activity in laser resurfacing plume and debris. Lasers Surg Med 1998;23:172–4.
     60 MMWR December 19, 2003
437. McKinley IB Jr, Ludlow MO. Hazards of laser smoke during endodontic therapy. J Endodontics 1994;20:558–9.
438. Favero MS, Bolyard EA. Microbiologic considerations. Disinfection
     and sterilization strategies and the potential for airborne transmission
     of bloodborne pathogens. Surg Clin North Am 1995;75:1071–89.
439. Association of Operating Room Nurses. Recommended practices for
     laser safety in the practice setting. In: Fogg D, ed. Standards, recommended practices and guidelines. Denver, CO: AORN, 2003.
440. Streifel AJ. Recognizing IAQ risk and implementing an IAQ program.
     In: Hansen W, ed. A guide to managing indoor air quality in health
     care organizations. Oakbrook Terrace, IL: Joint Commission on
     Accreditation of Healthcare Organizations Publishers, 1997.
441. US Department of Labor, Occupational Safety and Health Administration. Safety and health topics: laser/electrosurgery plume. Washington DC: US Department of Labor, Occupational Safety and Health
     Administration, 2003. Available at http://www.osha-slc.gov/SLTC/
     laserelectrosurgeryplume.
442. American Thoracic Society, CDC. Diagnostic standards and classification of tuberculosis in adults and children. Am J Resp Crit Care
     2000;161:1376–95.
443. Wells WF. Aerodynamics of droplet nuclei [Chapter 3]. In: Wells WF,
     ed. Airborne contagion and air hygiene: an ecological study of droplet
     infections. Cambridge, MA: Harvard University Press, 1955.
444. CDC. Prevention and treatment of tuberculosis among patients
     infected with human immunodeficiency virus: principles of therapy
     and revised recommendations. MMWR 1998;47(No. RR-20).
445. Smith WH, Davies D, Mason KD, Onions JP. Intraoral and pulmonary tuberculosis following dental treatment. Lancet 1982;1:842–4.
446. CDC. Self-reported tuberculin skin testing among Indian Health Service and Bureau of Prisons dentists, 1993. MMWR 1994;43:209–11.
447. Mikitka D, Mills SE, Dazey SE, Gabriel ME. Tuberculosis infection in
     US Air Force dentists. Am J Dent 1995;8:33–6.
448. CDC. World Health Organization consultation on public health issues
     related to bovine spongiform encephalopathy and the emergence of a
     new variant of Creutzfeldt-Jakob Disease. MMWR 1996;45:295–6.
449. CDC. Surveillance for Creutzfeldt-Jakob disease—United States.
     MMWR 1996;45:665–8.
450. Johnson RT, Gibbs CJ Jr. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339:
     1994–2004.
451. CDC. New variant CJD: fact sheet. Atlanta, GA: US Department of
     Health and Human Services, Public Health Service, CDC, 2003. Available at http://www.cdc.gov/ncidod/diseases/cjd/cjd_fact_sheet.htm.
452. Will RG, Ironside JW, Zeidler M, et al. A new variant of CreutzfeldtJakob disease in the UK. Lancet 1996;347:921–5.
453. Bruce ME, Will RG, Ironside JW, et al. Transmission to mice indicate
     that ‘new variant’ CJD is caused by the BSE agent. Nature 1997;389:
     498–501.
454. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis
     of prion strain variation and the aetiology of ‘new variant’ CJD.
     Nature 1996;383:685–90.
455. World Health Organization. Bovine spongiform encephalopathy (BSE).
     Fact Sheet No. 113. Geneva, Switzerland: World Health Organization, 2002. Available at http://www.who.int/mediacentre/factsheets/
     fs113/en/.
456. CDC. Probable variant Creutzfeldt-Jakob disease in a U.S. resident—
     Florida, 2002. MMWR 2002;51:927–9.
457. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant
     Creutzfeldt-Jakob disease and other human prion diseases with tonsil
     biopsy specimens. Lancet 1999;353:183–9.
458. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform
     encephalopathy: the National Institutes of Health series of 300 cases
     of experimentally transmitted disease. Ann Neurol 1994;35:513–29.
459. Brown P. Environmental causes of human spongiform encephalopathy [Chapter 8]. In: Baker HF, Baker HF, eds. Prion diseases. Totowa,
     NJ: Humana Press Inc, 1996:139–54.
460. Carp RI. Transmission of scrapie by oral route: effect of gingival scarification. Lancet 1982;1:170–1.
461. Ingrosso L, Pisani F, Pocchiari M. Transmission of the 263K scrapie
     strain by the dental route. J Gen Virol 1999;80:3043–7.
462. Bernoulli C, Siegfried J, Baumgartner G, et al. Danger of accidental
     person-to-person transmission of Creutzfeldt-Jakob disease by surgery.
     Lancet 1977;1:478–9.
463. Brown P, Gajdusek DC, Gibbs CJ Jr, Asher DM. Potential epidemic of
     Creutzfeldt-Jakob disease from human growth hormone therapy.
     N Engl J Med 1985;313:728–31.
464. CDC. Fatal degenerative neurologic disease in patients who received
     pituitary-derived human growth hormone. MMWR 1985;34:359–60,
     365–6.
465. Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D. Possible
     person-to-person transmission of Creutzfeldt-Jakob disease. N Engl
     J Med 1974;290:692–3.
466. CDC. Epidemiologic notes and reports: rapidly progressive dementia
     in a patient who received a cadaveric dura mater graft. MMWR
     1987;36:49–50, 55.
467. Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report.
     J Neurosurg 1988;69:766–9.
468. Kondo K, Kuroiwa Y. A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 1982;11:377–81.
469. Van Duijn CM, Delasnerie-Laupretre N, Masullo C, et al, and European Union (EU) Collaborative Study Group of Creutzfeldt-Jacob disease (CJD). Case-control study of risk factors of Creutzfeldt-Jakob
     disease in Europe during 1993–95. Lancet 1998;351:1081–5.
470. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a casecontrol study. Lancet 1999;353:693–7.
471. Blanquet-Grossard F, Sazdovitch V, Jean A, et al. Prion protein is not
     detectable in dental pulp from patients with Creutzfeldt-Jakob disease. J Dent Res 2000;79:700.
472. World Health Organization. Infection control guidelines for transmissible spongiform encephalopathies: report of a WHO consultation,
     Geneva, Switzerland, 23–26 March 1999. Geneva, Switzerland: World
     Health Organization, 2000. Available at http://www.who.int/emcdocuments/tse/whocdscsraph2003c.html.
473. Institute of Medicine, Committee on Quality of Health Care in
     America. Kohn LT, Corrigan JM, Donadlson MS, eds. To err is
     human: building a safe health system. Washington, DC: National Academy Press, 1999.
474. CDC. Framework for program evaluation in public health. MMWR
     1999;48(No. RR-11).